Healthcare

Pfizer in $4.1B Deal to Acquire Oncology Biotech NovaCure Sciences

Pfizer is acquiring NovaCure Sciences to bolster its late-stage oncology pipeline with three Phase III candidates.

AstraZeneca Bids $9.8B for Rare Disease Specialist GenePath

AstraZeneca has made an offer of $9.8 billion for rare disease biotech GenePath, expanding its rare oncology franchise.

Eli Lilly Acquires GLP-1 Drug Maker Metabolica for $6.3B

Eli Lilly is buying Metabolica to secure additional GLP-1 receptor agonist assets for its expanding obesity and diabetes portfolio.

Merck Acquires Gene Therapy Firm VectorBio for $2.9B

Merck has agreed to acquire VectorBio, gaining a clinical-stage gene therapy platform targeting rare neurological disorders.

Novartis Targets Digital Health Platform HealthSync for $1.8B

Novartis is pursuing the acquisition of HealthSync to integrate AI-driven patient engagement tools into its commercialisation strategy.

Bristol Myers Squibb Bids $7.4B for Haematology Biotech CellShield

BMS has submitted a takeover offer for CellShield, whose lead asset targets relapsed/refractory multiple myeloma.

Sanofi Acquires mRNA Vaccine Platform Maker VaxGen for $5.1B

Sanofi has agreed to buy VaxGen, securing proprietary mRNA lipid nanoparticle technology to compete with Pfizer-BioNTech.

Regeneron Acquires Ophthalmology Biotech RetinaRx for $2.6B

Regeneron is buying RetinaRx to expand into gene-based treatments for inherited retinal diseases beyond its flagship VEGF franchise.

Thermo Fisher to Acquire Lab Automation Firm AutoLab for $1.7B

Thermo Fisher Scientific is acquiring AutoLab to integrate robotic laboratory automation into its life sciences instruments segment.

UCB Acquires Neuroscience Startup NeuroPath for $3.0B

UCB has agreed to acquire NeuroPath, adding a clinical-stage asset targeting treatment-resistant epilepsy to its CNS portfolio.

Bain Capital Acquires Consumer Brands Group NaturePure for $2.6B

Bain Capital is buying NaturePure to build a platform of premium health-and-wellness consumer brands through buy-and-build acquisitions.

Warburg Pincus Acquires Healthcare Services Chain MedCare for $2.3B

Warburg Pincus is buying MedCare, a 300-clinic healthcare services chain, to consolidate primary care in high-growth urban markets.

EQT Partners Targets Nordic Pharmacy Chain NordMed for €1.9B

EQT Partners is pursuing a buyout of NordMed to create a pan-Nordic omnichannel pharmacy platform through further bolt-on acquisitions.